Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Neoadjuvant Chemotherapy in Primary Breast Cancer
NCT00548899Phase 2Completed
- Sponsor
- GBG Forschungs
- Start
- Nov 2007
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in breast cancer, sponsored by GBG Forschungs. Started Nov 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00548899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548899.